Dr. Lallos has over 20 years of drug discovery and development expertise for emerging and growth stage biotech companies with a focus on infectious disease, antiviral, and oncology research from discovery through Phase I clinical trials. As Project Leader for PharmaDirections, Inc., Dr. Lallos is responsible for client development and project management for the firm’s emerging biotech clients. She is responsible for the execution of client development plans, developing strategic plans, managing vendor relationships, and assisting her clients’ obtaining SBIR/STTR, venture capital, and other forms of financing. Prior to working with PharmaDirections, Lisa was a Senior Scientist at Idenix Pharmaceuticals where she was part of the team that successfully characterized anti-HCV compounds for single and combination resistance. She also led the Biology Protease Inhibitor Team, contributed to eight anti-HCV IND applications, and designed and implemented new experimental methods that increased sensitivity and reduced both time and cost. Earlier in her career, in addition to managing the virology department at Aphios Corporation, she was responsible for procuring HIV and influenza antiviral NIH SBIR grants, as well as designing innovative approaches to extend the firm’s core viral research into new areas including influenza, smallpox, and parvovirus. Additionally, she served on the board of the Boston chapter of the Healthcare Businesswomen’s Association as Director Programming and Secretary, receiving a LEAD award in 2013. Dr. Lallos has a BA in Biology from Oberlin College, received her MS and PhD in Viral Immunology from New York University, and completed her postdoctoral training at Harvard University. Dr. Lallos has over ten peer-reviewed publications and holds two patents.